Merck & Co Newsroom

Merck Decides To End Favezelimab Clinical Development Program, And Stop Enrollment In Phase 3 KEYFORM-008 Trial

Benzinga16:33 ET

Express News | Merck & Co Inc - Patients in Keyform-008 Trial May Continue Therapy Until Study Completion

Reuters16:30 ET

Express News | Merck & Co Inc - Discontinues Clinical Development Programs for Vibostolimab and Favezelimab

Reuters16:30 ET

Express News | Merck Provides Update on Keyvibe and Keyform Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations With Pembrolizumab

Reuters16:30 ET

Another Week, Another Index Record | Lkive Stock

Kevin TraversDec 16 10:42 ET

Dow's 115-Point Rally Highlighted By Gains In Honeywell, Nike Shares

MarketWatchDec 16 10:08 ET

Merck's KEYTRUDA Approved in Combination With Chemotherapy in China to Treat Lung Cancer

MT NewswiresDec 16 07:14 ET

Express News | Merck’s Keytruda® (Pembrolizumab) Approved in China in Combination With Chemotherapy as Neoadjuvant Treatment, Then Continued as Monotherapy After Surgery as Adjuvant Treatment for Patients With Resectable Stage II, Iiia or Iiib Nsclc

ReutersDec 16 06:45 ET

Weekly Buzz: Tech stocks hit high scores on ominous day

Kevin TraversDec 13 16:29 ET

Bicycle Therapeutics Reports Updates Across Zelenectide Pevedotin Program; Shares Slump

MT NewswiresDec 13 13:53 ET

Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report

BenzingaDec 13 12:15 ET

Market Mixed on Friday the 13th | Livestock

Kevin TraversDec 13 10:46 ET

Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients

BenzingaDec 13 07:50 ET

Merck & Co. Gets Key European Backing for Welireg in Two Uses

WSJDec 13 07:30 ET

Express News | Merck: Final Decision Is Expected in Q1 of 2025

ReutersDec 13 07:05 ET

Express News | Merck Receives Positive EU Chmp Opinion for Welireg® (Belzutifan) as Treatment for Adult Patients With Certain Types of Von Hippel-Lindau Disease-Associated Tumors and for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma

ReutersDec 13 07:05 ET

Express News | EMA's Chmp: Recommended Granting Conditional Marketing Authorisation for Welireg (Belzutifan)

ReutersDec 13 06:37 ET

Merck & Co To Go Ex-Dividend On December 16th, 2024 With 0.81 USD Dividend Per Share

Moomoo NewsDec 12 20:00 ET

Merck (MRK) Ascends While Market Falls: Some Facts to Note

Zacks Dec 12 17:00 ET

Thursday Ends in Index Declines | Wall Street Today

Kevin TraversDec 12 16:29 ET